These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22495349)

  • 1. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's disease.
    Searcy JL; Phelps JT; Pancani T; Kadish I; Popovic J; Anderson KL; Beckett TL; Murphy MP; Chen KC; Blalock EM; Landfield PW; Porter NM; Thibault O
    J Alzheimers Dis; 2012; 30(4):943-61. PubMed ID: 22495349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
    Blalock EM; Phelps JT; Pancani T; Searcy JL; Anderson KL; Gant JC; Popovic J; Avdiushko MG; Cohen DA; Chen KC; Porter NM; Thibault O
    PLoS One; 2010 Apr; 5(4):e10405. PubMed ID: 20454453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.
    Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E
    PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice.
    Masciopinto F; Di Pietro N; Corona C; Bomba M; Pipino C; Curcio M; Di Castelnuovo A; Ciavardelli D; Silvestri E; Canzoniero LM; Sekler I; Pandolfi A; Sensi SL
    Cell Death Dis; 2012 Dec; 3(12):e448. PubMed ID: 23254291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
    Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS
    Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice.
    Toba J; Nikkuni M; Ishizeki M; Yoshii A; Watamura N; Inoue T; Ohshima T
    Biochem Biophys Res Commun; 2016 May; 473(4):1039-1044. PubMed ID: 27059136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease.
    Gupta R; Gupta LK
    Pharmacol Biochem Behav; 2012 Aug; 102(2):184-90. PubMed ID: 22503969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice.
    Yu Y; Li X; Blanchard J; Li Y; Iqbal K; Liu F; Gong CX
    J Neural Transm (Vienna); 2015 Apr; 122(4):593-606. PubMed ID: 25113171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice.
    To AW; Ribe EM; Chuang TT; Schroeder JE; Lovestone S
    PLoS One; 2011 Feb; 6(2):e16991. PubMed ID: 21347323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
    Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
    Gamboa J; Blankenship DA; Niemi JP; Landreth GE; Karl M; Hilow E; Sundararajan S
    Neuroscience; 2010 Oct; 170(3):846-57. PubMed ID: 20691766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease.
    Mandrekar-Colucci S; Karlo JC; Landreth GE
    J Neurosci; 2012 Jul; 32(30):10117-28. PubMed ID: 22836247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
    Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
    J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.
    Dello Russo C; Gavrilyuk V; Weinberg G; Almeida A; Bolanos JP; Palmer J; Pelligrino D; Galea E; Feinstein DL
    J Biol Chem; 2003 Feb; 278(8):5828-36. PubMed ID: 12486128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.
    Nicolakakis N; Aboulkassim T; Ongali B; Lecrux C; Fernandes P; Rosa-Neto P; Tong XK; Hamel E
    J Neurosci; 2008 Sep; 28(37):9287-96. PubMed ID: 18784309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
    Yamanaka M; Ishikawa T; Griep A; Axt D; Kummer MP; Heneka MT
    J Neurosci; 2012 Nov; 32(48):17321-31. PubMed ID: 23197723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.
    Chu Y; Lund DD; Weiss RM; Brooks RM; Doshi H; Hajj GP; Sigmund CD; Heistad DD
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):523-32. PubMed ID: 23288158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.